Delivery Order SPE2DB22D2009-SPE2DB25FM1ET
- Not listed
- AmerisourceBergen Drug Corp was awarded a $7,085.19 delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 2, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector pharmaceutical product. The contract has a ceiling value of $5,495.86 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 2, 2025. The place of performance is the company's corporate office in Conshohocken, Pennsylvania. This award was competitively awarded with no...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract from the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, valued at $16,549.76, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 21, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector pharmaceutical product. The contract, valued at $7,567.40, carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,616.16 by the Defense Logistics Agency on September 16, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injector medication. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 17, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $13,248.86 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick autoinjectors, with performance in Conshohocken, Pennsylvania and completion by August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply arrangements with the federal government. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $46,352.82 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on September 24, 2025, with an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,386.83 on July 18, 2025, for the supply of Repatha 140 mg/ml SureClick prefilled auto-injectors. The contract is unclassified with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 21, 2025. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is funded through the Medical Supply Chain division within the...
- The Defense Logistics Agency awarded a delivery order valued at $26,823.30 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will take...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on August 14, 2025, with a ceiling value of $1,041.42 and an ultimate completion date of August 15, 2025. This competitive, firm fixed-price delivery order represents pharmaceutical supply to support military and federal healthcare requirements. The award is classified as a child contract, indicating it derives from a larger contract vehicle. This delivery order...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1ETDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $41,346.30 by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 29, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued with no set-aside designation, reflecting the open competition process through which it was awarded. This delivery order represents a child contract action under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime vehicle serves as a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. The Repatha auto-injector delivery supports the Defense Health Agency and other federal healthcare systems' pharmaceutical supply needs, consistent with DLA's mission to provide medical commodities to the Department of Defense and other authorized federal customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.3k | 8/28/25 |